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Skin substitutes are increasingly being used in the
treatment of dif®cult to heal wounds but their mech-
anisms of action are largely unknown. In this study,
using histology, immunostaining, ¯ow cytometry,
enzyme-linked immunosorbent assay, and reverse
transcription polymerase chain reaction, we deter-
mined the response to injury of a human bilayered
skin substitute. Meshing or scalpel fenestration of the
construct was found to stimulate keratinocyte migra-
tion and to decrease proliferation. By 24 h, ¯ow
cytometry of the keratinocyte component showed
that meshing was associated with a 33% decrease in
the number of cells in S phase (p < 0.01). An
approximately 2-fold decrease in staining for Ki67, a
proliferation marker, was observed with meshing of
human bilayered skin substitute. The process of ree-
pithelialization was apparent by 12 h, however, the
wounded human bilayered skin substitute was healed
by day 3, and a stratum corneum and fully strati®ed
epithelium were re-established by day 4. Reverse
transcription polymerase chain reaction analysis and
enzyme-linked immunosorbent assays showed that
the expression of acute proin¯ammatory cytokines
(interleukins 1a, 6, and 8, tumor necrosis factor a)
peaked by 12±24 h postinjury. The levels of mRNA
of certain growth factors (transforming growth fac-
tor b1, vascular endothelial growth factor, insulin-
like growth factor 2) but not others (platelet-derived
growth factors A and B, keratinocyte growth factor,
®broblast growth factors 1 and 7, transforming
growth factor b3) increased by 12 h and peaked by
1±3 d after injury, returning to normal by day 6.
Immunostaining for tumor necrosis factor a and
transforming growth factor b1 paralleled these ®nd-
ings by reverse transcription polymerase chain reac-
tion. We conclude that human bilayered skin
substitute, as a prototypic bilayered skin substitute, is
a truly dynamic living tissue, capable of responding
to physical injury in a staged and speci®c pattern
of cell migration, reepithelialization, and cytokine
expression. Key words: wound healing/tissue repair/skin
substitute/keratocytes/cytokines/growth factors. J Invest
Dermatol 119:653±660, 2002
O
ver the last several years, advances in tissue culture
and in the understanding of matrix proteins have
made it possible for investigators to construct
increasingly sophisticated skin substitutes. Some of
the skin substitutes are acellular, some contain
living cells, and others are bilayered, composed of both epidermal
and dermal cell types. The cells used in the preparation of these
bioengineered skin constructs are generally derived from neonatal
foreskin, whereas the initial matrix scaffold in which the cells are
grown varies from glycosaminoglycans, to bovine collagen, to
synthetic materials (Phillips, 1998; Falanga, 2000a). There has been
a great deal of interest in using these bioengineered skin constructs
in the treatment of burns and chronic wounds, where the need to
accelerate healing seems to be greatest. For at least two decades,
investigators have used human keratinocyte sheets, either auto-
logous or allogeneic, to treat burns and a variety of chronic
wounds. More recently, the ®eld has seen the approval by
regulatory agencies of a bilayered skin substitute for the treatment
of venous (Falanga et al, 1998; Brem et al, 2001) and diabetic foot
ulcers (Veves et al, 2001).
There is increasing recognition that skin substitutes will have an
important therapeutic role in ulcers that are dif®cult to heal and in
those where acceleration of healing can prevent further complica-
tions. The mechanisms of action of bioengineered skin in wound
repair is unclear, however. It has been argued that the cells in living
skin substitutes act ``smart'' in engineering terms. This concept
suggests that cells are able to sense and to adapt to their
environment, and to act appropriately in terms of their synthetic
repertoire, the dose and sequence of mediators produced, and the
timing of release of cytokines and growth factors (Falanga et al,
1998; Phillips, 1998; Falanga, 2000b). This concept also suggests
that skin substitutes may employ different mechanisms of action for
acute and chronic wounds. There is at present only limited
evidence for the mechanisms of action of bioengineered skin. In
chronic wounds, the data to date indicate that cells from allogeneic
skin substitutes are likely to have a very short life span in wounds,
suggesting that the bene®cial clinical effects of these living
constructs are not due to a permanent replacement of cells (Brain
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et al, 1989; Phillips et al, in press). Interestingly, investigators have
found that the application of skin substitutes to previously
nonhealing ulcers stimulates the edges of the wound to migrate
toward the center, the ``edge effect''. This observation has been
made with keratinocyte sheets as well as other types of
bioengineered skin and it suggests that a major role of skin
substitutes is to stimulate the endogenous healing process (Falanga,
2000b).
We have been interested in the mechanisms of action of
bioengineered skin as a whole, and particularly in how constructs
containing living cells are capable of stimulating the endogenous
process of wound repair. We have ®rst focused our attention on
how skin substitutes behave in response to injury, and whether they
are indeed capable of releasing cytokines and growth factors and
going through a process of repair. An added advantage of this
approach is that it can lead to fundamental insights into the healing
process in a well-de®ned but complex in vitro environment, more
similar to the in vivo situation. Also, many of the skin substitutes are
meshed or manipulated before application to wounds, and
therefore do go through a process of injury and repair.
Therefore, it becomes vitally important and clinically relevant,
even in terms of future improvements in these constructs, to know
the events associated with injury to bioengineered skin.
MATERIALS AND METHODS
Human bilayered skin substitute (HBSS) For these studies we used
a prototypic construct, an HBSS, which is commercially available as
Apligraf (Organogenesis, Canton, MA; licensed by Novartis
Pharmaceuticals, East Hanover, NJ) and whose composition and
construction have been previously described (Wilkins et al, 1994). HBSS
contains human dermal ®broblasts in a contracted collagen lattice
overlaid with a corni®ed epidermis. Keratinocytes and ®broblasts used in
the preparation of HBSS are grown from infant foreskins according to
published procedures (Wilkins et al, 1994; Falanga et al, 1998). Brie¯y,
®broblasts in suspension are mixed with a bovine type I collagen solution
and poured into culture transwells (Costar, Cambridge, MA). The
cultures are incubated for 6 d at 36°C, 10% CO2. During that time the
®broblasts contract the collagen to form a cellular dermal matrix. Human
keratinocytes are then seeded onto the surface of the lattice and the
construct is submerged for 4 d in medium that allows the keratinocytes
to cover the dermal matrix. After 4 d the constructs are cultured at the
air±liquid interface to promote the development of the epidermis, which
reaches maturity after 10 d at the air interface (Wilkins et al, 1994). In
these studies HBSS was used at 10±11 d post-airlift. HBSS is easy to
handle and to mesh, and therefore suitable for the types of experiments
described in this report (Fig 1).
In vitro wounding HBSS was wounded by passing it through a skin
mesher (1.5 cm 3 1 cm, Zimmer, Dover, OH), so as to create a 1.5±1
meshing ratio. For cytokine studies and for histologic evidence of
reepithelialization, cultures were kept at the air±liquid interphase and
incubated at 37°C. Biopsies of the HBSS and culture supernatants were
collected at 4 and 12 h, and at 1, 2, 3, and 6 d after wounding. Two
biopsies were taken at each time point. One biopsy was used for RNA
isolation for reverse transcription polymerase chain reaction (RT-PCR)
analysis and another biopsy was used for hematoxylin and eosin staining
for routine histologic analysis. The supernatant was removed for enzyme-
linked immunosorbent assay (ELISA) analysis. In other experiments, the
HBSS was injured by multiple 0.4 cm excisions, approximately 1.5 cm
apart, using a scalpel with a #15 blade (fenestration). The injured HBSS
was fully expanded and placed on its dermal component (i.e., the same
construct but without epidermis). In other experiments, HBSS was either
kept or placed back in its transwell, over the nutrient agar, immediately
after injury by meshing or fenestration. In that case, the construct was
either left undisturbed (control unlifted), lifted from its agar nutrient
transwell (control lifted), fenestrated with a scalpel, or meshed at a ratio
of 1.5±1. The culture medium used during and after injury to HBSS
consisted of the following formulation: Dulbecco's modi®ed Eagle's
medium 48%, Ham's nutrient mixture F-12 48%, L-glutamine 658 mg
per liter, hydrocortisone 0.4 mg per liter, insulin 5.0 mg per liter, human
transferrin 5.0 mg per ml, triiodothyronine 13.5 ng per liter,
ethanolamine 0.1 mM, O-phosphoethanolamine 14.0 mg per liter,
selenious acid 6.78 mg per liter, adenine 24.4 mg per liter, newborn
bovine serum 1.0%.
We also performed studies for determining the cytokine pro®le of the
dermal equivalent of HBSS. In this case, the dermal equivalent (without
keratinocyte component) was minced with a scalpel and its cytokine
pro®le at 7, 14, and 21 d was determined by RT-PCR.
Histologic processing Samples of HBSS were ®xed in 10% neutral
buffered formalin, rinsed in phosphate-buffered saline (PBS), dehydrated
through graded ethanols, cleared, in®ltrated, and embedded in paraf®n.
Five micron sections were cut on a microtome, af®xed to glass
microscope slides, dried, and then deparaf®nized and hydrated.
Immunohistochemistry Immunohistochemistry was performed on
formalin-®xed tissue. Brie¯y, the tissue was ®rst deparaf®nized and
treated with methanol hydrogen peroxide. Antigen retrieval was
Figure 1. Photomicrographs showing the HBSS as it is being
lifted from its nutrient agar, and after meshing (inset).
Table I. Primer sequences used in RT-PCR for
determining the expression of cytokines and growth factors
after injury to bioengineered skin
Primers Primer sequence
FGF-1 (5¢) gct gct gag gcc atg gct gaa
FGF-1 (3¢) aca gat ctc ttt aat cag aag aga ctg
FGF-2 (5¢) gga gtg tgt gct aac cgt tac ctg gct atg
FGF-2 (3¢) tca gct ctt agc aga cat tgg aag aaa aag
FGF-7 (5¢) ctt tgc tct aca gat cat gct ttc
FGF-7 (3¢) ttg cca tag gaa gaa agt ggg ctg
IL-1a (3¢) tag tgc cgt gag ttt ccc aga aga aga gga gg
IL-1a (5¢) caa gga gag cat ggt ggt agt agc aac caa cg
IL-6 (3¢) gaa gag ccc tca ggc tgg act g
IL-6 (5¢) atg aac tcc ttc tcc aca agc gc
IL-8 (3¢) tct cag ccc tct tca aaa act tct c
IL-8 (5¢) atg act tcc aag ctg gcc gtg gct
PDGF-A (3¢) ctg ctt cac cga gtg cta caa tac ttg ct
PDGF-A (5¢) aga agt cca ggt gag gtt aga gga gca t
PDGF-B (3¢) gcc gtc ttg tca tgc gtg tgc ttg aat ttc cg
PDGF-B (5¢) ctg tcc agg tga gaa aga tcg aga ttg tgc gg
TGF-a (3¢) ggc ctg ctt ctt ctg gct ggc a
TGF-a (5¢) atg gtc ccc tcg gct gga cag
TGF-b1 (3¢) agg ctc caa atg tag ggg cag g
TGF-b1 (5¢) gcc ctg gac acc aac tat tgc t
TGF-b3 (5¢) att acc tcc aag gtt ttc cg
TGF-b3 (3¢) gcc cgc ttc ttc ctc tga cc
TNF-a (3¢) gca atg atc cca aag tag acc tgc cca gac t
TNF-a (5¢) gag tga caa gcc tgt agc cca tgt tgt agc a
GAPDH (3¢) cat gtg ggc cat gag gtc cac cac
GAPDH (5¢) tga agg tcg gag tca acg gat ttg gt
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performed with 0.01 M citric acid pH 6.0 using a steamer for 20 min.
Slides were placed in 1 3 PBS with blocking serum (horse serum for
monoclonals and goat serum for the rabbit polyclonal antibodies). The
tissue was then treated with the primary antibody for 1 h at room
temperature. For these experiments, the primary antibodies were diluted
with 1 3 PBS and 0.1% bovine serum albumin. Secondary antibodies
were incubated with the sections for 1 h at room temperature.
Secondary antibodies were either antimouse horse IgG (dilution 1:200
for mouse primary antibodies) or antirabbit goat IgG (dilution 1:200 for
rabbit primary antibodies). Both antibodies were from Vector
(Burlingame, CA). The tertiary antibody was streptavidin horseradish
peroxidase conjugated (DAKO, Carpinteria, CA) diluted 1:400 and
incubated with the sections for 1 h at room temperature. Following that
step, the sections were treated with 3,3-diaminobenzidine
tetrahydrochloride (Zymed, San Francisco, CA) for 10 min and 0.5%
cupric sulfate in 0.9% NaCl for 5 min. The sections were counterstained
with hematoxylin (DAKO) for 10 s. We used the following primary
antibodies: antihuman rabbit transforming growth factor b1 (TGF-b1)
(V) (Santa Cruz Biotech, Santa Cruz, CA), at a dilution of 1:70;
antihuman mouse tumor necrosis factor a (TNF-a) (1E8-G6, Santa
Cruz), at a dilution of 1:30; antihuman mouse Ki67 at a dilution of 1:50
(Beckman Coulter, Miami, Fl, and DAKO).
Flow cytometry Flow cytometry of the keratinocyte component of
HBSS was performed 24 h after scalpel or meshing injury, in the
experiments where the construct was placed back on its nutrient agar.
The processing of HBSS for cell cycle analysis was performed according
to the following procedures. A section of HBSS (3 3 3 cm) was
removed from its transwell, placed in 15 ml of thermolysin (0.5 mg per
ml; Sigma, St. Louis, MI), and incubated at 37°C for 2 h. The tissue was
then moved to a tissue culture dish containing 10 ml of PBS. The
epidermis was separated from the dermis by gentle teasing with forceps.
In preparing the keratinocyte suspensions, the cells were disaggregated in
PBS utilizing a Medi machine (BD, St. Jose, CA) and a 50 mm ®lcon
®lter (BD), and cell viability (> 95%) was veri®ed using trypan blue
exclusion. Subsequently, the cells were washed in PBS and resuspended
in propidium iodide solution (DNA-Assay, New Concept Scienti®c,
Niagra Falls, NY), at a concentration of 1 3 106 cells per ml. Entry into
the S phase of the cell cycle and proliferative activity of cells derived
from dermis and epidermis was determined from a FACS Caliber ¯ow
cytometer (Becton Dickinson, St. Jose, CA). Cells were acquired using
CELLQuest software program (BD) with doublet discrimination. At least
25,000 events were acquired for each sample. The cells were then
analyzed utilizing the ModFIT LT software program (Verity Software
House, Topsham, ME).
Cytokine detection by RT-PCR and ELISA HBSS samples were
extracted using the Qiagen (Valencia, CA) Shredder/RNeasy extraction
procedure on approximately 0.5 cm2 biopsy. Moloney murine leukemia
virus (MMLV) reverse transcriptase was used to synthesize
complementary strands of DNA (cDNA). The PCR actual primers used
are shown in Table I. For each primer, the following concentrations
and reaction mix were used: 5 ml cDNA from the above procedure was
added to 31 ml DEPC-treated water, 5 ml 10 3 PCR buffer, 1 ml
10 mM dATP, 1 ml 10 mM dTTP, 1 ml 10 mM dGTP, 1 ml 10 mM
dCTP, 3 ml 25 mM MgCl2, and 0.4 ml Amplitaq enzyme in thin-walled
reaction tubes. A 2% agarose gel containing 1 ng per ml ethidium
bromide was viewed under ultraviolet light (312 nm). Stained gels were
photographed, and subsequently digitally captured using a CCD camera.
Intensities of band products were quanti®ed using image analysis software
(ImagePro, CA). Each of the cytokine measurements was corrected for
varying amounts of RNA by normalizing to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). Supernatants were also collected and frozen at
60°C until ready to be tested. Interleukin-1a (IL-1a) and IL-6 protein
levels were measured using R&D ELISA kits (R&D Systems,
Minneapolis, MN) according to the manufacturer's instruction.
RESULTS
In vitro reepithelialization of HBSS The ability over time of
the HBSS keratinocytes to migrate and close the wound in vitro
was determined by placing the entire bilayered construct over a
separate dermal equivalent (lower portion of HBSS). This was done
to more closely mimic in vivo wounding. The initial wounds were
approximately 4 mm in length. As shown in Fig 2, by 12 h an
epithelial tongue was seen at the wound margin as keratinocytes
began to migrate from the edges. Keratinocyte migration continued
over the next 2 d. By day 2, the wound was completely
reepithelialized with a multilayer of keratinocytes. By day 4 the
wound was completely covered with a well-differentiated
epidermis including a stratum corneum. In other experiments,
the HBSS response to injury was determined by keeping the
construct over its nutrient agar. There were histologic differences
between wounded and nonwounded HBSS in these experiments.
Figure 2. Photomicrographs showing the process of
reepithelialization of the HBSS after injury and application to its
dermal equivalent. (a) After injury. A circle has been placed over the
cross-section of HBSS, and the arrow indicates the dermal equivalent.
203. (b) Appearance of construct 12 h after injury. 203. (c) Appearance
of healing construct at day 2. 20 3. (d) Healed construct at day 4. 203.
Figure 3. Histologic appearance of the HBSS. (a) Before injury by
meshing; (b) 24 h after injury by meshing at a ratio of 1.5±1. 203.
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The nonwounded HBSS has a well-de®ned basal layer and a
compact stratum corneum (Fig 3). By 24 h after wounding, a very
noticeable change in the epidermal architecture was appreciated. As
shown in Fig 3, there was disruption of the granular layer, and the
epidermal cells acquired a more squamous-cell-like morphology,
with a less-de®ned basal layer. These morphologic changes
observed by histology point to an epidermis that has shifted to a
migratory state. This question was studied further by
immunohistochemistry and by staining for Ki67, a marker of
proliferation (Andreadis et al, 2001). As shown in Fig 4,
nonwounded HBSS had a high and regularly spaced number of
proliferating basal cell keratinocytes. Twenty-four hours after
wounding of the construct, however, one could see focally
diminished staining for Ki67 (Fig 4). In particular, there was
markedly less staining at the advancing epidermal tongue and
grouping of proliferating keratinocytes away from the edges. These
®ndings were present in all wounded specimens, either meshed or
perforated, and suggest that wounding of the construct is associated
with a dramatic shift of the basal keratinocytes from a proliferative
to a migratory state. To study this process further, we determined
the entry of cells into the S phase of the cell cycle. As shown in
Fig 5, simply lifting the bioengineered skin construct from its
nutrient transwell was associated with an increase in the percentage
of cells entering the S phase. In agreement with the
immunohistochemical studies with Ki67, however, wounding led
to a decrease in the percentage of cells entering S phase. This result
was seen after injury by either meshing or fenestration, and was
observed in eight out of eight experiments (p < 0.01). The dermal
component of HBSS also underwent histologic and
immunohistochemical changes indicative of increased
proliferation and synthetic activity. In particular, the dermal
component was approximately 20% greater in size, with a greater
number of ®broblasts (data not shown).
Cytokine and growth factor expression after injury The
histologic and immunohistochemical changes just described were
accompanied by substantial alterations in the pattern of pro-
in¯ammatory cytokines and growth factors, as measured by RT-
PCR. These results are shown in Figs 6±9. Figures 6 and 7
illustrate representative blots, whereas Figs 8 and 9 represent the
summary of determinations of at least three separate experiments
for each cytokine and growth factor level. As can be seen from
Figs 8 and 9, there is a staged progression of cytokine and growth
factor production. In general, an increase in the levels of pro-
in¯ammatory cytokines (IL-1a, IL-1b, IL-6, IL-8, IL-11, and
TNF-a) is observed quickly, in the ®rst 12 h. The time by which
maximal levels of these cytokines are observed was different,
however. For example, IL-1a and TNF-a levels showed maximal
production by 24 h, whereas IL-1b and IL-11 were maximal by 12
and 72 h, respectively. In contrast, the levels of growth factors
increased at later time points. For example, as seen in Figs 8 and 9,
insulin-like growth factor 2 (IGF-2) and TGF-b1 levels did not
increase until 48 h after injury to the construct. In some cases, such
as with TGF-a and TGF-b3, no signi®cant increase was observed
throughout the observation period. In the case of platelet-derived
growth factor B (PDGF-B), peak production activity was seen after
72 h.
Figure 4. Immunohistochemical staining for Ki67 of the HBSS.
(a) Before injury by meshing; (b) 24 h after injury by meshing at a ratio
of 1.5±1. 203.
Figure 5. Results of ¯ow cytometry indicating entry into S phase
of the keratinocyte component of the HBSS after injury by
meshing or by fenestration (perforation) with a scalpel. Results
represent the mean 6 SD from eight experiments.
Figure 6. Levels of pro-in¯ammatory cytokines, as measured by
RT-PCR, in the HBSS at various intervals after meshing injury.
The ®gure shows a representative blot.
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The staged alteration in cytokine and growth factor expression
observed by PCR was also demonstrable at the protein level for
selected cytokines we measured. These measurements were
performed by ELISA and immunohistochemistry. As early as 4 h
postinjury, signi®cant levels of IL-1a protein levels were detected
in the culture supernatant (Fig 10), with peak concentrations
observed by 24 h. An increase in IL-6 mRNA accumulation had
been observed 4 h postinjury by RT-PCR. As shown in Fig 11,
IL-6 protein was detected in the culture supernatant 8 h later and
continued to increase over the next 48 h. PDGF was detected in
cell lysates at 24 h postinjury with continued protein accumulation
over the next 3 d (not shown). It should be noted that the extent of
injury to the HBSS is also important. Thus, using RT-PCR 24 h
after injury to HBSS, we found that, compared to scalpel injury,
meshing injury increases the levels of cytokines (data not shown).
This ®nding was most notable for IL-1a (318%), IL-11 (250%), IL-
6 (150%), and IL-8 (135%).
Dynamic changes in the production of cytokines and growth
factors by HBSS after injury were in large part due to the epidermal
component. To determine this, we measured mRNA levels by
RT-PCR in studies where the dermal equivalent of HBSS
(prepared without the keratinocyte component) was injured by
mincing with a scalpel. In these experiments (actual results now
shown), if a band had a relative intensity of < 0.05 after correcting
for GAPDH, it was considered negative. The 0.05 level was
determined by a serial dilution of a GAPDH PCR product on an
ethidium bromide stained agarose gel, and a measure was taken of
the lane next to the last visible band. Baseline levels, before injury,
are represented by day 7 postcast of the dermal equivalent. We
found a 3-fold increase in the levels of IL-1 and IGF-2 at days 14
and 21 postcasting (p < 0.05). Conversely, the levels of most
cytokines and growth factors were already maximal in the dermal
equivalent at baseline. This was true of IL-6, IL-8, TGF-b1, TGF-
b3, IGF-1, connective tissue growth factor, TGF-a, ®broblast
growth factor 7 (FGF-7), and vascular endothelial growth factor
(VEGF).
To obtain a visual representation of the changes in expression of
pro-in¯ammatory cytokines and growth factors demonstrated by
RT-PCR and by measurements of protein levels, we performed
immunohistochemistry using antibodies to TNF-a and TGF-b1.
Figure 12 shows how TNF-a is expressed by basal cells early after
injury, with maximum expression between 12 and 24 h.
Conversely, as shown in Fig 13, TGF-b1 was increasingly
expressed much later after injury, as observed by 72 h. By this
time point, there was intense expression of TGF-b1 not only in the
epidermis but also in dermal ®broblasts, with evidence of dermal
thickening and increased ®broblast number. Interestingly, the
distribution of these cytokines and their intensities did not differ at
the center of the bioengineered skin construct compared to its
meshed edge, suggesting that perhaps the signals of injury are
propagated over substantial distances.
DISCUSSION
We report that bioengineered skin, as shown here with a living
bilayered skin construct, is capable of de®ned cellular and molecular
responses after wounding. These responses appear to mimic the
in vivo repair process (Singer and Clark, 1999; Freedberg et al, 2001)
and can provide fundamental insights into wound healing. Thus,
we have demonstrated that an HBSS is able to reepithelialize itself
and to undergo a staged response to wounding in terms of the
production of pro-in¯ammatory cytokines (early) and growth
factors (late). The process of reepithelialization appears to be
associated with a marked shift of keratinocytes from proliferation to
migration. Together, these ®ndings indicate the potential of this
in vitro model to enhance our understanding of the healing process
Figure 8. Levels of cytokines (mean 6 SD),
as measured by RT-PCR, in the HBSS at
various times after meshing injury. For these
experiments, the stained gels were photographed
and subsequently digitally captured using a CCD
camera. Intensities of band products were
quanti®ed using image software (ImagePro, CA).
Each of the cytokines was corrected for varying
amounts of RNA by normalizing to GAPDH.
Each experiment was repeated at least three times.
Figure 7. Levels of growth factors, as measured by RT-PCR, in
the HBSS at various intervals after meshing injury. The ®gure
shows a representative blot.
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and provide critical insights into the possible mechanisms of action
of bioengineered skin. Admittedly, further studies will be needed to
precisely link the changes we have observed in the bioengineered
construct studied in this report with human skin treated the same
way.
The ®nding that HBSS is able to reepithelialize itself after
meshing is in agreement with a previous more limited observation
(Garlick and Taichman, 1994). We chose here to place the meshed
HBSS over a bed composed of the isolated dermal component of
the construct. In our opinion, this situation mimics more closely
the in vivo setting, where bioengineered skin is placed over a dermal
bed. It should be noted, however, that migration and resurfacing
are also observed after the construct is placed over tissue culture
plastic. Indeed, it appears that the time required for reepithelializa-
tion is actually faster over plastic, with resurfacing observed by 24 h
(Milstone et al, 2000). It may very well be that plastic represents
continued and greater injury to the construct or that the ®broblast-
rich dermal matrix may actually slow down epithelial resurfacing.
This discrepancy is of more than passing interest, because it
provides us with a theoretical view that the construct is capable of
even faster migratory activity. Studying the possible mechanisms
involved may perhaps enhance the clinical effectiveness of these
constructs. Of great interest is the shift we observed from a high
proliferative to a migratory state of HBSS after wounding. The
effect was quite marked, as shown by histology, immunohisto-
chemistry, and ¯ow cytometry, and suggests that, when wounded,
the cellular components of human skin, particularly keratinocytes,
may also shift from proliferation to migration. This relationship
between migration and proliferation, which has been previously
described (Fransson and Hammar, 1992; Sarret et al, 1992;
Woodley et al, 1993), makes both theoretical and practical sense,
for it is dif®cult if not impossible for cells to migrate and proliferate
at the same time. There could be some useful manipulations of this
system, which we did not try in these studies. For example, it is
Figure 9. Levels of growth factors (mean 6
SD), as measured by RT-PCR, in the HBSS
at various times after meshing injury. For
these experiments, the stained gels were
photographed and subsequently digitally captured
using a CCD camera. Intensities of band products
were quanti®ed using image software (ImagePro,
CA). Each of the cytokines was corrected for
varying amounts of RNA by normalizing to
GAPDH. Each experiment was repeated at least
three times.
Figure 10. Protein levels of IL-1a, as measured by ELISA, and
mRNA levels in the HBSS after meshing injury. Each point
represents the mean of triplicate determinations.
Figure 11. Protein levels of IL-6, as measured by ELISA, and
mRNA levels in the HBSS after meshing injury. Each point
represents the mean of triplicate determinations.
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theoretically possible that by priming the skin with an antiproli-
ferative agent we might be able to enhance the ``migratory shift''.
Regardless, this ®nding provides useful insights into the healing
process and, with additional studies comparing these ®ndings with
those observed with human skin, could represent proof of principle
of the value of bioengineered skin as a model for wounding and for
generating additional hypotheses. Our results are consistent with
previous ®ndings demonstrating delayed proliferation following an
initial migratory phase (Winter, 1962). More indirectly, others have
shown individual genetically marked cells within the wound bed,
indicating that individual cells had migrated from the wound edges
without having undergone replication (Garlick and Taichman,
1994). Another useful question is whether bioengineered skin
could cause a ``migratory shift'' within wounds. This idea is
supported by the clinical observations that skin substitutes,
including keratinocyte sheets, cause an ``edge effect'', with rather
dramatic migration of keratinocytes from the wound's edges
(Falanga, 2000b).
The ®rst phase of wound healing is characterized by a number of
overlapping events, including the production of pro-in¯ammatory
cytokines. This pro-in¯ammatory stage occurs within the ®rst 24 h
after injury. IL-1a and TNF-a represent the primary cytokines for
pro-in¯ammatory responses. IL-1a upregulates the production of
IL-6, IL-8, and TGF-a (Ansel et al, 1990). In addition,
keratinocytes maintain substantial amounts of IL-1a in intracellular
stores. These stores are released when a biologic or mechanical
insult occurs in the skin. In this study we detected increased levels
of IL-1a in the culture supernatant 4±12 h postinjury, pointing to
the rapid release of this cytokine from its intracellular stores. A
direct effect of IL-1 release is the upregulation of IL-6 production.
By 12 h, we observed an increase in IL-6 mRNA levels. IL-6 has
been associated with the release of colony stimulating factors (CSFs)
by keratinocytes and with an increase of acute phase proteins in
serum (Imokawa et al, 1996). Although not shown, we found
increased CSF production in HBSS after injury. There is a cascade
of these pro-in¯ammatory cytokines, which has been found in vivo
and which was clearly reproduced in these studies. Another
example is IL-8, a chemokine with angiogenic properties (Koch et
al, 1992). Similarly to IL-6, IL-8 is upregulated by the release of IL-
1. Consistent with this upregulation, we found its mRNA levels to
be increased by 12 h.
The second phase of wound healing is associated with growth-
oriented cytokines and factors, capable of initiating extracellular
matrix deposition and cellular proliferation. Generally, this stage
begins early (4±12 h) from the time of injury and can last longer
than the in¯ammatory stage (> 6 d). IGF-2, PDGF-A, PDGF-B,
TGF-bs, and VEGF are all upregulated during the growth phase of
cutaneous repair, and this is the reason why we determined their
levels in this study. We found that the levels of these cytokines and
growth factors were upregulated in wounded HBSS after 24 h, a
timing quite consistent with what has been observed in vivo. The
TGF-bs have multiple functions throughout wound healing,
including playing a critical role in the deposition of extracellular
matrix proteins and preventing hyperproliferation of keratinocytes
after wound closure (Roberts et al, 1986). In this study, TGF-b1
mRNA was upregulated by 24 h and TGF-b3 was constitutively
expressed. Taken together, our ®ndings with HBSS closely follow
the pattern reported after in vivo injury to the skin.
In summary, using a prototypic bilayered living skin construct,
we report that bioengineered skin acts as a living tissue, capable of
appropriately responding to wounding injury. We expect that other
types of living skin substitutes will behave similarly, particularly if
their structure allows for dermal±epidermal interactions. Our results
also suggest that the accelerated healing observed with the
therapeutic use of these constructs may be related to their ability
to deliver a cascade of cytokines and growth factors. In many ways,
as indicated by our results, bioengineered skin behaves like an acute
wound. It is interesting to consider that, when these constructs are
used therapeutically in dif®cult to heal wounds, they may be acting
as an ``acute wound'' placed in a chronic wound, and thus are able
to re-condition and reset the healing environment.
This work was supported by grants to Dr. Falanga from the National Institutes of
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